세계의 호르몬 대체 요법 시장 보고서(2025년)

Hormone Replacement Therapy Global Market Report 2025

US $ 4,490 ￦ 6,226,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,000,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,773,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

호르몬 대체 요법 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 예측 기간 동안의 성장은 호르몬 장애의 유병률 증가, 갱년기 건강에 대한 인식 제고, 전 세계적으로 고령화 인구 증가, 신흥 시장의 의료 서비스 접근성 확대, 최소 침습적 치료 옵션에 대한 수요 증가에 기인할 수 있습니다. 이 기간의 주요 동향으로는 생물학적 동일 호르몬 제제의 발전, 첨단 경피 의약품 전달 기술, 유전자 프로파일링을 기반으로 한 개인 맞춤형 호르몬 요법의 개발, 장기간 작용형 호르몬 주사제의 혁신, 호르몬 요법 관리를 위한 원격 의료 통합의 발전 등이 있습니다.

폐경기 여성 인구의 증가는 향후 호르몬 대체 요법 시장의 확장을 촉진할 것으로 예상됩니다. 폐경 후 여성은 생식 호르몬의 자연적 감소로 인해 월경이 영구적으로 중단된 여성으로, 일반적으로 마지막 월경 후 12개월 후에 발생합니다. 이 여성의 증가세는 여성의 수명 연장 및 노령화 인구 증가와 연관되어 있습니다. 호르몬 대체 요법은 폐경 후 여성의 일반적인 증상인 열감과 야간 발한을 완화하여 삶의 질을 향상시킵니다. 이 요법은 개인에 맞는 치료를 통해 호르몬 균형을 유지하여 불편함을 줄이고 전반적인 웰빙을 지원합니다. 예를 들어, 2022년 7월, 미국에 본사를 둔 의료 기관인 Mayo Clinic Health System은 전 세계 폐경 및 폐경 후 여성 인구가 2030년까지 12억 명에 달하고, 매년 4,700만 명의 새로운 환자가 발생할 것으로 예상된다고 밝혔습니다. 이로 인해 폐경 후 여성의 증가가 호르몬 대체 요법 시장 성장을 촉진하고 있습니다.

호르몬 대체 요법 시장 선도 기업들은 치료 효과와 환자 순응도를 향상시키기 위해 생물학적 동일 호르몬 제제 등 혁신적인 제형 개발에 집중하고 있습니다. 생물학적 동일 호르몬 제제는 인체에서 자연적으로 생성되는 호르몬과 화학적으로 동일한 호르몬을 사용해 부작용을 줄이면서 더 자연스럽고 효율적인 증상 완화를 목표로 합니다. 예를 들어(2024년) 5월 인도 기반 제약사 Jagsonpal Pharmaceuticals Ltd.는 생물학적 동일 호르몬 대체 요법(HRT)인 MemUp을 출시했습니다. 이 고급 치료법은 에스트라디올과 프로게스테론을 단일 일일 경구 캡슐에 결합했습니다. MemUp은 폐경 증상인 열감과 야간 발한을 효과적으로 완화하며, 치료 과정을 간소화해 환자 편의성과 순응도를 향상시키도록 설계되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 호르몬 대체 요법 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 호르몬 대체 요법 시장 : 성장률 분석
• 세계의 호르몬 대체 요법 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 호르몬 대체 요법 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 호르몬 대체 요법 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

• 세계의 호르몬 대체 요법 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 에스트로겐 대체 요법
• 인간성장호르몬(hGH) 대체 요법
• 갑상선 호르몬 대체 요법
• 테스토스테론 대체 요법
• 기타
• 세계의 호르몬 대체 요법 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 폐경
• 갑상선 기능 저하증
• 남성 성선 기능 저하증
• 성장 호르몬 결핍증
• 기타
• 세계의 호르몬 대체 요법 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구
• 경피
• 주사
• 기타 행정
• 세계의 호르몬 대체 요법 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타
• 세계의 호르몬 대체 요법 시장 : 에스트로겐 대체 요법 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구 에스트로겐
• 경피 에스트로겐
• 국소 에스트로겐
• 질 에스트로겐
• 주사용 에스트로겐
• 세계의 호르몬 대체 요법 시장 : 인간 성장 호르몬(hGH) 대체 요법 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 소마트로핀
• 소마트렘
• 재조합 인간 성장 호르몬(rhGH)
• PEG화 hGH
• 기타 인간성장호르몬(hGH) 대체 요법
• 세계의 호르몬 대체 요법 시장 : 갑상선 호르몬 대체 요법 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 레보티록신(T4)
• 리오티로닌(T3)
• 천연건조 갑상선(NDT)
• 리오티로닌(T3) 또는 레보티록신(T4)의 병용 요법
• 세계의 호르몬 대체 요법 시장 : 테스토스테론 대체 요법 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 젤과 크림
• 주사
• 패치
• 경구 테스토스테론
• 펠렛
• 세계의 호르몬 대체 요법 시장 : 기타 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 프로게스테론 대체 요법
• 에스트로겐 프로게스테론 병용 요법
• 데히드로에피안드로스테론 요법
• 멜라토닌 대체 요법

제7장 지역 및 국가별 분석

• 세계의 호르몬 대체 요법 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 호르몬 대체 요법 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 호르몬 대체 요법 시장 : 경쟁 구도
• 호르몬 대체 요법 시장 : 기업 프로파일
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Bayer AG
  • Sanofi SA

제31장 기타 주요 기업 및 혁신 기업

• Abbott Laboratories
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Bausch Health Companies Inc.
• Cipla Inc.
• Gedeon Richter Plc.
• Lupin Limited
• Orion Corporation
• Halozyme Therapeutics Inc.
• Theramex HQ UK Limited

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 호르몬 대체 요법 시장(2029년) : 새로운 기회를 제공하는 국가
• 호르몬 대체 요법 시장(2029년) : 새로운 기회를 제공하는 부문
• 호르몬 대체 요법 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

HBR

영문 목차

영문목차

Hormone replacement therapy (HRT) is a medical procedure that provides the body with hormones that it no longer produces in adequate amounts. It is primarily used to ease symptoms linked to menopause, including hot flashes, night sweats, mood changes, and more.

The main types of hormone replacement therapy consist of estrogen replacement therapy, human growth hormone replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and others. Estrogen replacement therapy involves supplementing estrogen hormones to reduce symptoms caused by estrogen deficiency, such as those experienced during menopause. This therapy is applied for various conditions like menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, among others, and can be administered orally, through the skin, by injection, and other methods. The primary distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others.

The hormone replacement therapy market research report is one of a series of new reports from The Business Research Company that provides hormone replacement therapy market statistics, including the hormone replacement therapy industry global market size, regional shares, competitors with the hormone replacement therapy market share, detailed hormone replacement therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the hormone replacement therapy industry. This hormone replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hormone replacement therapy market size has grown strongly in recent years. It will grow from $25.06 billion in 2024 to $27.28 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth during the historic period can be attributed to the rising prevalence of menopausal symptoms among aging women, increased awareness of hormone deficiency treatments, longer life expectancy and an aging population, growing global healthcare spending, and the increasing use of estrogen therapy in postmenopausal women.

The hormone replacement therapy market size is expected to see strong growth in the next few years. It will grow to $37.90 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be attributed to the increasing prevalence of hormonal disorders, heightened awareness of menopausal health, a growing aging population globally, expanded healthcare access in emerging markets, and a rising demand for minimally invasive treatment options. Key trends in this period include progress in bio-identical hormone formulations, advanced transdermal drug delivery technologies, the development of personalized hormone therapies based on genetic profiling, innovations in long-acting hormone injectables, and advancements in telehealth integration for managing hormone therapy.

The growing number of postmenopausal women is expected to drive the expansion of the hormone replacement therapy market in the future. Postmenopausal women are those who have permanently ceased menstruation due to the natural reduction of reproductive hormones, usually occurring 12 months after their last period. This increase in postmenopausal women is linked to rising life expectancy, as women are living longer, leading to a larger aging female population undergoing menopause. Hormone replacement therapy benefits postmenopausal women by easing common symptoms like hot flashes and night sweats, thereby enhancing quality of life. It helps maintain hormonal balance through personalized treatments, reducing discomfort and supporting overall well-being. For example, in July 2022, Mayo Clinic Health System, a US-based healthcare organization, reported that the global population of menopausal and postmenopausal women is expected to reach 1.2 billion by 2030, with 47 million new cases annually. Consequently, the increasing number of postmenopausal women is fueling the growth of the hormone replacement therapy market.

Leading companies in the hormone replacement therapy market are concentrating on developing innovative formulations, including bio-identical hormone formulations, to enhance treatment effectiveness and patient adherence. Bio-identical hormone formulations utilize hormones that are chemically identical to those naturally produced by the human body, aiming to offer more natural and efficient symptom relief with fewer side effects. For example, in May 2024, Jagsonpal Pharmaceuticals Ltd., an India-based pharmaceutical firm, introduced MemUp, a bio-identical hormone replacement therapy (HRT). This advanced therapy combines estradiol and progesterone in a single, once-daily oral capsule. MemUp is designed to effectively relieve common menopausal symptoms such as hot flashes and night sweats while simplifying the treatment process to improve patient convenience and compliance.

In December 2024, Likarda, a US-based biotechnology firm, collaborated with VitalTE LifeSciences to develop extended-release injectable hormone therapies. This partnership seeks to improve patient convenience, increase treatment adherence, and provide a non-surgical alternative to conventional hormone delivery methods through innovative, long-acting formulations. VitalTE LifeSciences is a US-based biotechnology company focused on creating advanced hormone replacement therapy solutions.

Major players in the hormone replacement therapy market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Cipla Inc., Gedeon Richter Plc., Lupin Limited, Orion Corporation, Halozyme Therapeutics Inc., Theramex HQ UK Limited.

North America was the largest region in the hormone replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hormone replacement therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hormone replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormone replacement therapy market includes revenues earned by entities through hormone level assessment, personalized treatment planning, prescription and administration of hormone therapies, patient monitoring, and follow-up care to manage symptoms related to hormonal imbalances. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormone Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormone replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormone replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormone replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: Estrogen Replacement Therapy; Human Growth Hormone Replacement Therapy; Thyroid Hormone Replacement Therapy; Testosterone Replacement Therapy; Other Therapy Types
• 2) By Indication: Menopause; Hypothyroidism; Male Hypogonadism; Growth Hormone Deficiency; Other Indications
• 3) By Route Of Administration: Oral; Transdermal; Injectable; Other Of Administartions
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Estrogen Replacement Therapy: Oral Estrogen; Transdermal Estrogen; Topical Estrogen; Vaginal Estrogen; Injectable Estrogen
• 2) By Human Growth Hormone (hGH) Replacement Therap: Somatropin; Somatrem; Recombinant Human Growth Hormone (rhGH); Pegylated hGH; Other Human Growth Hormone (hGH) Replacement Therapies
• 3) By Thyroid Hormone Replacement Therapy: Levothyroxine (T4); Liothyronine (T3); Natural Desiccated Thyroid (NDT); Combination T3 Or T4 Therapy
• 4) By Testosterone Replacement Therapy: Gels And Creams; Injections; Patches; Oral Testosterone; Pellets
• 5) By Other Therapy Types: Progesterone Replacement Therapy; Combined Estrogen-Progesterone Therapy; Dehydroepiandrosterone Therapy; Melatonin Replacement Therapy
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormone Replacement Therapy Market Characteristics

3. Hormone Replacement Therapy Market Trends And Strategies

4. Hormone Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hormone Replacement Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hormone Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hormone Replacement Therapy Market Growth Rate Analysis
• 5.4. Global Hormone Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hormone Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hormone Replacement Therapy Total Addressable Market (TAM)

6. Hormone Replacement Therapy Market Segmentation

• 6.1. Global Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Hormone Replacement Therapy
• Testosterone Replacement Therapy
• Other Therapy Types
• 6.2. Global Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Other Indications
• 6.3. Global Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Transdermal
• Injectable
• Other Of Administartions
• 6.4. Global Hormone Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Estrogen Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Estrogen
• Transdermal Estrogen
• Topical Estrogen
• Vaginal Estrogen
• Injectable Estrogen
• 6.6. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Human Growth Hormone (hGH) Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Somatropin
• Somatrem
• Recombinant Human Growth Hormone (rhGH)
• Pegylated hGH
• Other Human Growth Hormone (hGH) Replacement Therapies
• 6.7. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Levothyroxine (T4)
• Liothyronine (T3)
• Natural Desiccated Thyroid (NDT)
• Combination Liothyronine (T3) Or Levothyroxine (T4) Therapy
• 6.8. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Testosterone Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gels And Creams
• Injections
• Patches
• Oral Testosterone
• Pellets
• 6.9. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Other Therapy Types,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Progesterone Replacement Therapy
• Combined Estrogen-Progesterone Therapy
• Dehydroepiandrosterone Therapy
• Melatonin Replacement Therapy

7. Hormone Replacement Therapy Market Regional And Country Analysis

• 7.1. Global Hormone Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hormone Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormone Replacement Therapy Market

• 8.1. Asia-Pacific Hormone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormone Replacement Therapy Market

• 9.1. China Hormone Replacement Therapy Market Overview
• 9.2. China Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormone Replacement Therapy Market

• 10.1. India Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormone Replacement Therapy Market

• 11.1. Japan Hormone Replacement Therapy Market Overview
• 11.2. Japan Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormone Replacement Therapy Market

• 12.1. Australia Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormone Replacement Therapy Market

• 13.1. Indonesia Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormone Replacement Therapy Market

• 14.1. South Korea Hormone Replacement Therapy Market Overview
• 14.2. South Korea Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormone Replacement Therapy Market

• 15.1. Western Europe Hormone Replacement Therapy Market Overview
• 15.2. Western Europe Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormone Replacement Therapy Market

• 16.1. UK Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormone Replacement Therapy Market

• 17.1. Germany Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormone Replacement Therapy Market

• 18.1. France Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormone Replacement Therapy Market

• 19.1. Italy Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormone Replacement Therapy Market

• 20.1. Spain Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormone Replacement Therapy Market

• 21.1. Eastern Europe Hormone Replacement Therapy Market Overview
• 21.2. Eastern Europe Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormone Replacement Therapy Market

• 22.1. Russia Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormone Replacement Therapy Market

• 23.1. North America Hormone Replacement Therapy Market Overview
• 23.2. North America Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormone Replacement Therapy Market

• 24.1. USA Hormone Replacement Therapy Market Overview
• 24.2. USA Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormone Replacement Therapy Market

• 25.1. Canada Hormone Replacement Therapy Market Overview
• 25.2. Canada Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormone Replacement Therapy Market

• 26.1. South America Hormone Replacement Therapy Market Overview
• 26.2. South America Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormone Replacement Therapy Market

• 27.1. Brazil Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormone Replacement Therapy Market

• 28.1. Middle East Hormone Replacement Therapy Market Overview
• 28.2. Middle East Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormone Replacement Therapy Market

• 29.1. Africa Hormone Replacement Therapy Market Overview
• 29.2. Africa Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormone Replacement Therapy Market Competitive Landscape And Company Profiles

• 30.1. Hormone Replacement Therapy Market Competitive Landscape
• 30.2. Hormone Replacement Therapy Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Hormone Replacement Therapy Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Novartis AG
• 31.3. GSK plc
• 31.4. Eli Lilly and Company
• 31.5. Amgen Inc.
• 31.6. Novo Nordisk A/S
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Mylan N.V.
• 31.9. Bausch Health Companies Inc.
• 31.10. Cipla Inc.
• 31.11. Gedeon Richter Plc.
• 31.12. Lupin Limited
• 31.13. Orion Corporation
• 31.14. Halozyme Therapeutics Inc.
• 31.15. Theramex HQ UK Limited

32. Global Hormone Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormone Replacement Therapy Market

34. Recent Developments In The Hormone Replacement Therapy Market

35. Hormone Replacement Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Hormone Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hormone Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hormone Replacement Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료